返回
Zhaoke Ophthalmology Limited（06622.HK）價格
06622.HK 股價走勢圖
ZHAOKE OPHTH-B (06622.HK)
Zhaoke Ophthalmology Limited
HK$3.42
-2%
$-0.07
盤中： Jan 19, 15:24:16 HKT
暫無資料Earnings FAQ
06622.HK 最近的每股盈餘與預期相比如何？
Zhaoke Ophthalmology Limited 06622.HK 上一季度的收入表現如何？
Zhaoke Ophthalmology Limited 的收入預期是多少？
Zhaoke Ophthalmology Limited 的盈利品質評分是多少？
Zhaoke Ophthalmology Limited 何時發布財報？
Zhaoke Ophthalmology Limited 的預期收益是多少？
Zhaoke Ophthalmology Limited 是否超出收益預期？
關鍵數據
前收市價
$3.52
開盤價
$3.49
當日範圍
$3.38 - $3.49
52週區間
$1.26 - $4.6
交易量
697.0K
平均成交量
1.0M
每股盈餘 (TTM)
-0.56
股息收益率
--
市值
$1.8B
什麼是 ZHAOKE OPHTH-B？
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. The company is headquartered in Guangzhou, Guangdong and currently employs 270 full-time employees. The company went IPO on 2021-04-29. The product pipelines primarily include NVK002 (Atropine) for myopia, CsA Ophthalmic Gel for DED and TAB014 (Bevacizumab) for wAMD. The products are primarily uses to treat eye diseases across both the front and the back of the eye, including dry eye disease (DED), myopia, presbyopia, wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), glaucoma and corneal epithelial dysfunction (CED). The firm conducts its business in the domestic market and overseas markets.